Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)

  1. Sáez-Peñataro, J.
  2. Torres, F.
  3. Bartra, J.
  4. Bascuas, J.
  5. Vilella, A.
  6. Tortajada, M.
  7. Quesada, S.
  8. González, E.
  9. López-Suñé, E.
  10. Castells, A.
  11. Serrano, S.
  12. Camacho, C.
  13. Trilla, A.
  14. Calvo, G.
  15. Bertran, M.-J.
  16. Carrera, C.
  17. Galisteo, M.
  18. Gómez, S.
  19. Muñoz, R.
  20. Pascal, M.
  21. Pérez, J.L.
  22. Aparicio, L.
  23. Bañuelos, S.
  24. Cano, P.
  25. de Dios, V.
  26. Massó, A.
  27. Puente, C.
  28. Sánchez, C.
  29. Villarreal, M.
  30. Show all authors +
Journal:
BioDrugs

ISSN: 1179-190X 1173-8804

Year of publication: 2022

Volume: 36

Issue: 4

Pages: 509-520

Type: Article

DOI: 10.1007/S40259-022-00543-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals